Life sciences regulatory & compliance partner Kellie Combs (Washington, D.C.) will present at the Food and Drug Law Institute’s conference “Digital Health Technology and Regulation During COVID-19 and Beyond” on September 10. The virtual event will focus on digital health regulation and enforcement policies and exemptions the U.S. Food and Drug Administration has recently implemented.
Kellie’s panel “Regulation of Digital Health During and After COVID-19” will compare the traditional approval pathways available for software-as-medical device products and address the impact of increased funding for telehealth and remote patient monitoring tools under the CARES Act.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.